Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

<i>In Vitro</i> and <i>In Vivo</i> Antibacterial Activities of Omadacycline, a Novel Aminomethylcycline

3 Dec 2013

Abstract excerpt

Omadacycline is the first intravenous and oral 9-aminomethylcycline in clinical development for use against multiple infectious diseases including acute bacterial skin and skin structure infections (ABSSSI), community-acquired bacterial pneumonia (CABP), and urinary tract infections (UTI). The comparative in vitro activity of omadacycline was determined against a broad panel of Gram-positive clinical isolates,...

Source

Identifiers

PMID: 24295985
DOI: 10.1128/aac.01242-13

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 31 Aug 2026.

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

<i>In Vitro</i> and <i>In Vivo</i> Antibacterial Activities of Omadacycline, a Novel AminomethylcyclinePMID 24295985Read ↗

Omadacycline invitro activity against a molecularly characterized collection of clinical isolates with known acquired tetracycline resistance mechanisms.Semantic proximity Read ↗

In vitro Activity and Heteroresistance of Omadacycline Against Clinical Staphylococcus aureus Isolates From China Reveal the Impact of Omadacycline Susceptibility by Branched-Chain Amino Acid Transport System II Carrier Protein, Na/Pi Cotransporter Family Protein, and Fibronectin-Binding ProteinSemantic proximity Read ↗

<i>In Vitro</i> and <i>In Vivo</i> Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant <i>Staphylococcus aureus</i> StrainsSemantic proximity Read ↗

Antibacterial Efficacy of Eravacycline <i>In Vivo</i> against Gram-Positive and Gram-Negative OrganismsSemantic proximity Read ↗

In vitro antimicrobial activity and resistance mechanisms of the new generation tetracycline agents, eravacycline, omadacycline, and tigecycline against clinical Staphylococcus aureus isolatesSemantic proximity Read ↗

Uncovering the mechanism of action of a historical antimicrobial against <i>S. aureus</i> and <i>A. baumannii</i>Semantic proximity Read ↗

Antibiotic-adjuvants abolish resistance conferred by the <i>Staphylococcus aureus</i> erythromycin resistance methyltransferase in an <i>Escherichia coli</i> modelSemantic proximity Read ↗

Omadacycline Efficacy against Enterococcus faecalis Isolated in China: In Vitro Activity, Heteroresistance, and Resistance Mechanisms.Semantic proximity Read ↗

<i>In Vitro</i> Activity of Plazomicin against 5,015 Gram-Negative and Gram-Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012Semantic proximity Read ↗

<i>In vitro</i> and <i>in vivo</i> activity profiles of broad-spectrum bacterial ATP synthase inhibitorsSemantic proximity Read ↗

<i>In Vitro</i> and <i>In Vivo</i> Characterization of the Novel Oxabicyclooctane-Linked Bacterial Topoisomerase Inhibitor AM-8722, a Selective, Potent Inhibitor of Bacterial DNA GyraseSemantic proximity Read ↗

Tigecycline - how powerful is it in the fight against antibiotic-resistant bacteria?Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.